Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-04-23

Clinical Trial Update: Dysport® Injection in the Treatment of Chronic Lateral Epicondylitis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Dysport injections for chronic lateral epicondylitis (tennis elbow) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dysport (abobotulinumtoxinA)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Tennis Elbow | Phase 3 | Status: COMPLETED